These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1286979)

  • 41. Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation.
    van der Meer A; Joosten I; Schattenberg AV; de Witte TJ; Allebes WA
    Br J Haematol; 2000 Nov; 111(2):685-94. PubMed ID: 11122122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay.
    Fassy J; Tsalkitzi K; Salavagione E; Hamouda-Tekaya N; Braud VM
    Immunology; 2017 Apr; 150(4):489-494. PubMed ID: 28004383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Standardization of a micro-cytotoxicity assay for human natural killer cell lytic activity.
    Mariani E; Monaco MC; Sgobbi S; de Zwart JF; Mariani AR; Facchini A
    J Immunol Methods; 1994 Jun; 172(2):173-8. PubMed ID: 8034970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
    Wiltrout RH; Frost P; Cummings GD
    J Natl Cancer Inst; 1978 Jul; 61(1):183-8. PubMed ID: 97392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity.
    Blomberg K; Ulfstedt AC
    J Immunol Methods; 1993 Mar; 160(1):27-34. PubMed ID: 8450237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increase of donor-specific cytotoxic T lymphocyte precursors after transfusion.
    Vandekerckhove BA; van Bree S; Zhang L; Datema G; Zantvoort F; Claas FH
    Transplantation; 1989 Oct; 48(4):672-5. PubMed ID: 2799922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of the direct beta counter Matrix 96 for cytotoxic assays: simultaneous processing and reading of 96 wells using a 51Cr-retention assay.
    Hillman GG; Roessler N; Fulbright RS; Pontes JE; Haas GP
    Cancer Immunol Immunother; 1993 Jun; 36(6):351-6. PubMed ID: 8500108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF).
    Kolber MA; Quinones RR; Gress RE; Henkart PA
    J Immunol Methods; 1988 Apr; 108(1-2):255-64. PubMed ID: 3258339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Europium-labelled target cells in an assay of natural killer cell activity. II. A novel non-radioactive method based on time-resolved fluorescence. significance and specificity of the method.
    Blomberg K; Granberg C; Hemmilä I; Lövgren T
    J Immunol Methods; 1986 Aug; 92(1):117-23. PubMed ID: 3745921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation.
    Kircher B; Niederwieser D; Gächter A; Lindner B; Mitterschiffthaler A; Urban C; Greinix H; Peters C; Lätzer K; Gastl G; Nachbaur D
    Int J Lab Hematol; 2008 Dec; 30(6):499-507. PubMed ID: 18522713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
    Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J
    Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EBV cell-lines (LCL) and E- cells as stimulator cells for limiting dilution analysis (LDA) of alloreactive IL-2-secreting cells (IL-2-SC) and cytotoxic precursors (CTLp). Comparison of their stimulator capacity and ability to generate specific alloreactivity.
    Lantz O; Alard P; Chavanel G; Fries D; Senik A; Charpentier B
    J Immunol Methods; 1991 Mar; 137(1):121-32. PubMed ID: 1849154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NK cytotoxicity and alloreactivity against neuroblastoma cell lines in vitro: comparison of Europium fluorometry assay and quantification by RT-PCR.
    Paillard C; Halle P; Tchirkov A; Confland C; Veyrat-Masson R; Quainon F; Perreira B; Rochette E; Pfeiffer M; Lang P; Deméocq F; Kanold J
    J Immunol Methods; 2012 Jun; 380(1-2):56-64. PubMed ID: 22516232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial.
    Scheibenbogen C; Romero P; Rivoltini L; Herr W; Schmittel A; Cerottini JC; Woelfel T; Eggermont AM; Keilholz U
    J Immunol Methods; 2000 Oct; 244(1-2):81-9. PubMed ID: 11033021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement of cytotoxic T lymphocyte precursor frequencies reveals cryptic HLA class I mismatches in the context of unrelated donor bone marrow transplantation.
    O'Shea J; Madrigal A; Davey N; Brookes P; Scott I; Firman H; Lechler R; Goldman J; Batchelor R
    Transplantation; 1997 Nov; 64(9):1353-6. PubMed ID: 9371679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity.
    Lichtenfels R; Biddison WE; Schulz H; Vogt AB; Martin R
    J Immunol Methods; 1994 Jun; 172(2):227-39. PubMed ID: 7518485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New approaches for monitoring CTL activity in clinical trials.
    Malyguine A; Strobl S; Zaritskaya L; Baseler M; Shafer-Weaver K
    Adv Exp Med Biol; 2007; 601():273-84. PubMed ID: 17713015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors.
    Man S; Lechler RI; Batchelor JR; Sharrock CE
    Eur J Immunol; 1990 Apr; 20(4):847-54. PubMed ID: 2112094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta galactosidase release as an alternative to chromium release in cytotoxic T-cell assays.
    Bachy M; Bonnin-Rivalland A; Tilliet V; Trannoy E
    J Immunol Methods; 1999 Nov; 230(1-2):37-46. PubMed ID: 10594352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.